1,000
Participants
Start Date
October 14, 2024
Primary Completion Date
July 31, 2025
Study Completion Date
December 31, 2025
Dihydroartemisinin-Piperaquine
Treatment will be with DP (females less than 13 years old and all males) or chloroquine alone (females 13 years old or older).
Chloroquine
Treatment will be with CQ alone if female and 13 years old or older in both intervention arms.
Sulfadoxine-pyrimethamine-amodiaquine
Treatment in Arm 2 (females less than 13 years old and all males).
RECRUITING
Malaria Alert Centre, Blantyre
Kamuzu University of Health Sciences
OTHER
Liverpool School of Tropical Medicine
OTHER